Steven L. Basta

President and CEO of Phathom Pharmaceuticals

As of Nov 9, 2026: Steven L. Basta (CEO, PHAT) reported no shares bought or sold themselves in the last 12 months (Form 4). PHAT's Quality Score is -4. Scores as of 9:50 AM ET, 15 minutes behind.

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Feb 10: stock award (12,362 PHAT shares).

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Steven L. Basta reported

None in the last 12 months, as filed.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See PHAT's 14 chart checksSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

Steven L. Basta's companies

Where Steven L. Basta files, with the stock's Quality Score
StockTradesQuality Score

Alerts for Steven L. Basta

An email for each Form 4 Steven L. Basta files, with the stock's Quality Score.
Set an alert

A free account. No card.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Feb 10, 2026.

Free to reuse with a link to this page.

How to cite

Breakaway, Steven L. Basta: President and CEO at PHAT, insider trades, Feb 10, 2026, getbreakaway.com/insiders/steven-l-basta

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Phathom Pharmaceuticals

Insider trades by person

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.